Revolutionizing Patient-Reported Outcomes Analysis for Oncology Drug Development Using Population Models.

However, when we plotted the QoL score change from baseline data over time for each participant, a decreasing trend was observed in the treatment arm ( Fig. 1C ).

also in 47,180 other papers